UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Strategy Inc
MSTR
|
+$745M |
| 3 |
EA
Electronic Arts
EA
|
+$725M |
| 4 |
TotalEnergies
TTE
|
+$639M |
| 5 |
Walmart Inc
WMT
|
+$585M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.87B |
| 2 |
Apple
AAPL
|
+$1.41B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 5 |
Southwest Airlines
LUV
|
+$727M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.52% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 6.68% |
| 4 | Industrials | 6.61% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BTA
4976
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $1.94M | ﹤0.01% |
208,805
-6,010
| -3% | -$57K |
|
4977
Columbus McKinnon
CMCO
$550M
| $1.94M | ﹤0.01% |
112,299
+54,502
| +94% | +$874K |
|
4978
Monte Rosa Therapeutics
GLUE
$1.35B
| $1.93M | ﹤0.01% |
123,000
+50,905
| +71% | +$686K |
|
4979
CALL
ResMed
RMD
$32.8B
| $1.93M | ﹤0.01% |
8,000
-16,000
| -67% | -$4.09M |
|
|
CTRA
4980
PUT
DELISTED
Coterra Energy
CTRA
| $1.93M | ﹤0.01% |
73,200
-40,000
| -35% | -$1.01M |
|
4981
iShares Emerging Markets Equity Factor ETF
EMGF
$1.91B
| $1.92M | ﹤0.01% |
33,232
-790
| -2% | -$45.5K |
|
4982
NovoCure
NVCR
$2.02B
| $1.92M | ﹤0.01% |
148,519
+66,544
| +81% | +$854K |
|
4983
Herbalife
HLF
$1.28B
| $1.92M | ﹤0.01% |
148,883
-509,771
| -77% | -$5.4M |
|
|
SEPN
4984
Septerna Inc
SEPN
$2.11B
| $1.92M | ﹤0.01% |
68,817
+9,771
| +17% | +$233K |
|
4985
Barrett Business Services
BBSI
$800M
| $1.92M | ﹤0.01% |
52,977
+20,528
| +63% | +$786K |
|
4986
Aquestive Therapeutics
AQST
$533M
| $1.92M | ﹤0.01% |
296,445
-202,591
| -41% | -$1.26M |
|
|
ISD
4987
PGIM High Yield Bond Fund
ISD
$419M
| $1.91M | ﹤0.01% |
132,252
+4,770
| +4% | +$68.9K |
|
4988
Xerox
XRX
$412M
| $1.91M | ﹤0.01% |
806,801
-1,342,176
| -62% | -$3.97M |
|
|
HELP
4989
Cybin Inc
HELP
$710M
| $1.91M | ﹤0.01% |
233,714
-70,026
| -23% | -$451K |
|
4990
ICL Group
ICL
$6.96B
| $1.91M | ﹤0.01% |
334,624
-62,409
| -16% | -$361K |
|
4991
Mizuho Financial
MFG
$134B
| $1.91M | ﹤0.01% |
260,729
+126,518
| +94% | +$865K |
|
4992
POET Technologies
POET
$1.54B
| $1.91M | ﹤0.01% |
301,274
+230,588
| +326% | +$1.46M |
|
|
ELVR
4993
Elevra Lithium Ltd
ELVR
$1.23B
| $1.91M | ﹤0.01% |
36,275
+31,124
| +604% | +$1.07M |
|
4994
Allogene Therapeutics
ALLO
$683M
| $1.9M | ﹤0.01% |
1,389,593
-2,181,564
| -61% | -$2.88M |
|
4995
Kyverna Therapeutics
KYTX
$500M
| $1.9M | ﹤0.01% |
202,187
+44,765
| +28% | +$332K |
|
4996
BlackRock Floating Rate Income Strategies Fund
FRA
$392M
| $1.9M | ﹤0.01% |
160,911
+61,535
| +62% | +$751K |
|
4997
Annexon
ANNX
$862M
| $1.89M | ﹤0.01% |
377,104
+30,965
| +9% | +$118K |
|
4998
PUT
Equity Residential
EQR
$24.2B
| $1.89M | ﹤0.01% |
30,000
+17,000
| +131% | +$1.04M |
|
4999
German American Bancorp
GABC
$1.92B
| $1.89M | ﹤0.01% |
48,250
+198
| +0.4% | +$7.81K |
|
5000
Lufax Holding
LU
$1.31B
| $1.89M | ﹤0.01% |
738,033
-833,147
| -53% | -$2.46M |
|
Similar funds
UBS Group's Q4 2025 Portfolio in Review
As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.
- UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
- UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
- UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
- UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
- UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
- UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.